Cardiac Dimensions
PrivateLast Round
Series E
Mar 20, 2025
Total Funding Raised
$180M
Company Overview
Cardiac Dimensions is a medical device company that develops interventional tools for the treatment of heart failure and mitral valve regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cardiac Dimensions Comparables
Compare Cardiac Dimensions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Polares Medical | 87% | |
| Valcare Medical | 83% | |
| 4C Medical Technologies, Inc. | 83% |
Cardiac Dimensions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Mar 20, 2025 | ||||
| Series D | Jan 5, 2023 | ||||
| Series C | Sep 29, 2020 | ||||
| Series B | Apr 26, 2018 | ||||
| VC Round | Mar 11, 2015 | ||||
VC Round | Apr 16, 2014 |
Key People
Founding team and executive leadership
Cardiac Dimensions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MPM Capital | Series D |
| Frazier Healthcare Partners | Series D |
| EQT Life Sciences | Series D, Series C, VC Round |
| Claret Capital Partners | Series E |
| Arboretum Ventures | VC Round, Series D, Series B, Series C |
| InterWest Partners | Series D |
| Hostplus Superannuation Fund | Series D, Series B, Series C, Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2025
William T. Abraham, MD, appointed as new Chief Medical Officer.
- Mar 20, 2025
$53M round completed.
Recent news
Latest coverage and updates
- expands_offices_inJul 8, 2026
Cardiac Dimensions Pty. Ltd. expanded offices in Europe on Jul 8th '25.
Cardiac Dimensions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cardiac Dimensions's valuation, stock price, and market status.
Is Cardiac Dimensions a public or private company?
Cardiac Dimensions is a private company.
What is the current stock price of Cardiac Dimensions?
Cardiac Dimensions is a private company with no public stock price. No recent secondary market data is available.
How much is Cardiac Dimensions worth (valuation)?
Valuation information for Cardiac Dimensions is not publicly available.
Can I buy Cardiac Dimensions stock?
Cardiac Dimensions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cardiac Dimensions's last funding round?
Cardiac Dimensions's most recent funding round was Series E on March 20, 2025.
Who are the main investors in Cardiac Dimensions?
Key investors in Cardiac Dimensions include EQT Life Sciences, Ally Bridge Group, Horizon 3 Healthcare, M.H. Carnegie & Co, Lumira Ventures.
Will Cardiac Dimensions IPO soon?
No public IPO plans have been announced for Cardiac Dimensions.
How can I track Cardiac Dimensions secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cardiac Dimensions's secondary market activity and sign up for updates.